In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Hospitals and clinics should plan to spend 11% to 13% more for prescription drugs in 2025 compared to last year, according to new research. For the second consecutive year, Keytruda was the costliest ...

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

Ocrelizumab may be safe during pregnancy, and treatment may be resumed while breastfeeding. Credit: Andrey Zhernovoy via Shutterstock. At the American Academy of Neurology (AAN) 2025 Annual Meeting ...

(AP Photo/Mark Schiefelbein) WASHINGTON (AP) — A new government task force will consider big changes to America’s intelligence community and examine whether material about the origins of COVID-19 and ...

WASHINGTON — Rep. Ronny Jackson is gearing up another investigation of the origins of COVID-19 — and wants to bring Dr. Anthony Fauci and a US-based coronavirus researcher credited with ...

Five years ago, the COVID-19 pandemic first swept across the U.S., infecting millions and claiming hundreds of thousands of lives. Scientists are already concerned about the next airborne threat ...

The MUSETTE trial found no additional benefit in higher doses of ocrelizumab for RMS compared to the standard 600 mg dose. The 600 mg dose of ocrelizumab remains optimal for slowing disability ...

NEW YORK, April 9 (Reuters) - A violent U.S. Treasury selloff, evoking the COVID-era "dash for cash," has reignited fears of fragility in the world’s biggest bond market. The $29-trillion ...

has begun to lay out the details of its plan to woo back thousands of service members who were involuntarily discharged over their refusal to receive the COVID-19 vaccination. Tim Dill ...

“I wasn’t able to move, my heart rate was really high,” the 24-year-old from Melbourne, who was diagnosed with long COVID after a severe infection in February 2022, says. Phoebe Kinrade ...